Ligands of the endothelial-enriched tunica interna endothelial cell kinase 2 (Tie2) are markedly imbalanced in severe infections associated with vascular leakage, yet regulation of the receptor itself has been understudied in this context. Here, we show that TIE2 gene expression may constitute a novel vascular barrier control mechanism in diverse infections. Tie2 expression declined rapidly in wide-ranging models of leak-associated infections, including anthrax, influenza, malaria, and sepsis. Forced Tie2 suppression sufficed to attenuate barrier function and sensitize endothelium to permeability mediators. Rapid reduction of pulmonary Tie2 in otherwise healthy animals attenuated downstream kinase signaling to the barrier effector vascular endothelial (VE)-cadherin and induced vascular leakage. Compared with wild-type littermates, mice possessing one allele of Tie2 suffered more severe vascular leakage and higher mortality in two different sepsis models. Common genetic variants that influence TIE2 expression were then sought in the HapMap3 cohort. Remarkably, each of the three strongest predicted cis-acting SNPs in HapMap3 was also associated with the risk of acute respiratory distress syndrome (ARDS) in an intensive care unit cohort of 1,614 subjects. The haplotype associated with the highest TIE2 expression conferred a 28% reduction in the risk of ARDS independent of other major clinical variables, including disease severity. In contrast, the most common haplotype was associated with both the lowest TIE2 expression and 31% higher ARDS risk. Together, the results implicate common genetic variation at the TIE2 locus as a determinant of vascular leak-related clinical outcomes from common infections, suggesting new tools to identify individuals at unusual risk for deleterious complications of infection.
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Tie2 | endothelium | infection | angiopoietin | permeability A mong vascular-enriched receptor tyrosine kinases, Tie2 is unusual in at least two functional aspects. First, Tie2 phosphorylation is tightly controlled by the interplay of several proteins: a paralogous receptor, Tie1; a tyrosine phosphatase, vascular endothelial-protein tyrosine phosphatase (VE-PTP); and two secreted ligands, angiopoietin (Angpt)-1 and Angpt-2, the latter of which can act as an agonist, partial agonist, or antagonist depending upon context (1) (2) (3) (4) (5) (6) . Second, unlike classic growth factor receptors, Tie2 is heavily expressed and phosphorylated throughout the quiescent adult vasculature (7) , suggesting that Tie2 signaling has one or more roles in vascular maintenance.
Based largely on Angpt-1 overexpression studies, Tie2 has been implicated in vascular barrier defense (8, 9) . However, adultspecific deletion of Angpt-1 does not appear to trigger vascular leakage (10) . Moreover, Angpt-1 has repeatedly been ascribed functions that are independent of Tie2 (11) (12) (13) . Finally, observational studies in humans suffering clinical manifestations of vascular leakage have consistently shown a marked imbalance in Tie2 ligands tilting in favor of Angpt-2 (reviewed in 14). Although decreased Tie2 activity has been inferred from these reports, the role of TIE2 gene expression has not been directly queried experimentally or in clinical settings.
This question is important not only for understanding control mechanisms of the circulatory system but also to guide the development of strategies to predict, stratify, and treat patients affected by acute vascular leakage. If tonic Tie2 signaling is indeed necessary for vascular barrier maintenance, then reducing the pool of receptors could constitute a ligand-independent means to attenuate barrier-protective signaling in the endothelium. We therefore hypothesized that the level of Tie2 expression modulates the sensitivity of blood vessels, and thereby the entire organism, to noxious stimuli. Cellular, rodent, and human genetics studies were undertaken to test this concept.
Results
Tie2 Suppression Is a Common Feature of Diverse, Leak-Associated Infectious Diseases. Experimental sepsis induces Angpt-2 expression and release, reduces Tie2 activation, and leads to vascular leakage, whereas Angpt-2 blockade or Angpt-1 administration
Significance
Major infections, such as influenza and bacterial sepsis, kill millions of individuals yearly, most commonly from complications affecting the vasculature, such as acute respiratory distress syndrome. Poor outcomes from rare infections, such as Ebola virus disease, have also been linked to the vasculature. The basis for prominent vascular involvement in infectious syndromes remains poorly understood. The present work shows that humans exhibit common, yet highly consequential, genetic variation in the ability to sustain expression of a key homeostatic vascular receptor called tunica interna endothelial cell kinase 2. The results suggest that host determinants of the molecular vascular response to infection may have a heretofore underappreciated impact on clinical outcomes. They also suggest new means to identify at-risk individuals and personalize future therapies.
enhances Tie2 activation and counteracts leakage (1, 6, (15) (16) (17) . The role of TIE2 gene expression has not been fully investigated in this and related settings. We therefore studied models of viral, protozoal, and bacterial infection whose clinical manifestations derive, in part, from pronounced vascular leakage. Mice infected with influenza virus or Plasmodium parasites, the causative agent of malaria, exhibited, respectively, 85% and 58% decreased TIE2 expression at the time of disease onset compared with baseline levels ( Fig. 1 A and B) . Tie2 transcripts also fell sharply in mouse lungs after systemic Gram-negative bacterial LPS administration (Fig. 1C) . Finally, Tie2 was also suppressed in mouse lungs following systemic administration of the anthrax lethal toxin (LT) (18) (Fig. 1D ). These findings show that Tie2 suppression is shared among diverse infections.
Tie2 Suppression Compromises Basal Endothelial Barrier Function.
Angpt-1 has been shown to enhance barrier defense against permeability mediators present in sepsis (16, 19) . However, it is debated whether this effect is dependent on signaling through Tie2 or alternative pathways (12, 13) . To investigate the role of Tie2 expression in barrier defense, we transfected human microvascular endothelial cells (HMVECs) with a control lentivirus or one encoding a Tie2 shRNA and selected successive passages using puromycin. After confirming >95% cell positivity for the shRNA construct, we observed stable, dose-dependent suppression of Tie2 (Fig. S1 A-C) . Coapplication of Angpt-1 with LPS restored barrier function in Tie2 intact cells but not in Tie2 low cells ( Fig. 2A) . To model the flux of macromolecules that characterizes vascular leak in vivo, we applied fluorescently labeled albumin to confluent HMVEC monolayers and measured its translocation to the abluminal side (Fig. 2B) Fig. 2 C and D) . These results show that intact Tie2 expression is necessary for basal barrier function, whereas Tie2 suppression is sufficient to weaken barrier function. Second, intact Tie2 expression is necessary for barrier defense against permeability mediators. Third, intact Tie2 expression is critical to achieve maximum barrier defense conferred by Angpt-1.
Acute Suppression of Tie2 Is Sufficient to Cause Vascular Leakage. To determine the consequences of rapid Tie2 suppression in vivo, we developed siRNA targeting Tie2 (siTie2) with backbone modifications and liposomal packaging suitable for targeted delivery to lung following i.v. injection into otherwise healthy adult animals ( Fig. 3 A-C and Fig. S2 A-D). There was no dropout of endothelium, as evidenced by intact expression of the marker CD31 despite a reduction in the activated form of Tie2 (Fig. S2E) . Instead, the barrier effector protein, vascular endothelial (VE)-cadherin, was markedly attenuated both in the microcirculation ( suffices to promote vascular leakage ( Fig. 3 J and K) . Furthermore, lungs of mice injected with siTie2 demonstrated widespread perivascular cuffing, a pathological sign of edema ( Fig. 3 L and M) .
Tie2 Suppression Mimics Infection-Associated Signaling Impairments but Does Not Induce Inflammation. Tie2 expression at the endothelial surface provides a modulatable target for affecting barrier function via VE-cadherin. To combat leakage in bacterial sepsis, activation of Akt downstream of Tie2 appears to be critical for connecting Tie2 to VE-cadherin, whereas in experimental anthrax, Tie2's barrier-protective effect appears to be signaled through the MAP kinase cascade (18) . Moreover, whether Tie2 suppression contributes to endothelial inflammation has not been addressed despite data that Tie2 activation blunts inflammation (15) . LPS administration promoted endothelial inflammation and Tie2 suppression (Fig. 4A) . Activation of Akt and ERK1/2 was significantly diminished in siTie2 mice compared with control counterparts (Fig. 4B ). This pattern of changes mimicked the effects of systemic LPS (Fig. 4C) . Finally, siTie2 mice exhibited no induction of inflammatory adhesion molecules in vitro or in vivo (Fig. S3 A-C) and no infiltration of activated leukocytes (Fig. 4 D-F) . Collectively, these results show that a fall in Tie2 expression is sufficient to promote barrier-weakening alterations in kinase signaling without inducing endothelial inflammation.
Degree of Basal Tie2 Expression Influences Susceptibility to Vascular
Leakage and Mortality in Sepsis. Whereas KO mice for Tie2 are embryonically lethal, heterozygotes have ∼50% reduced expression of Tie2 but no reported basal phenotype (21) . Compared with septic WT littermates, septic Tie2 heterozygotes (Tie2 +/− ) had lower total Tie2 protein and mRNA in the lung and less abundant phosphorylated Tie2 (Fig. 5A and Fig. S4 A-D) . Tie2 heterozygotes suffered significantly worse vascular leakage in response to LPS compared with WT littermates (Tie2 +/+ ) ( Fig. 5 B and C) . Of note, we observed no genotype-dependent differences in the expression of Angpt-1, Angpt-2, or endothelial inflammatory adhesion proteins (Fig. S4 E-I) . Finally, we compared survival of Tie2 heterozygotes with WT littermates in the LPS model and a model of ruptured appendicitis (cecal ligation and perforation). In either model, WT littermates displayed an absolute survival advantage exceeding 40% (Fig. 5 D and E) . (22, 23) . Based on the increased susceptibility of Tie2 heterozygous mice to sepsis, we hypothesized that population diversity in the set point for TIE2 gene expression may be associated with adverse clinical outcomes. We specifically focused on the development of acute respiratory distress syndrome (ARDS), a complication characterized by excess fluid in the lung that arises, in part, from pulmonary vascular leakage. We surveyed the European population in HapMap3 for SNPs around the TIE2 locus that could affect TIE2 gene expression [i.e., cis-expression quantitative trait loci (eQTLs)] (24). In a 2-Mb interval centered on the transcriptional start site (TSS) of TIE2, 1,184 potential SNPs were identified (Fig. 6A ). Of these SNPs, 16 achieved P < 0.01. Three of the most strongly associated SNPs, rs3780315, rs7876024, and rs581724, were located near the TSS in introns annotated as ECspecific enhancer regions, associated with heavily acetylated histones and/or EC-specific euchromatin (Fig. 6B) . These SNPs were not in linkage disequilibrium (Fig. 6C) . Expression of Tie2 in HapMap cell lines was significantly associated with genotype at each of the three loci (Fig. 6C) . We then performed focused germ-line genotype analysis at the TIE2 locus in a large cohort of critically ill subjects (Table S1 ). Cases were defined by the diagnosis of ARDS according to standard definitions, whereas controls were critically ill, and thus at risk for ARDS, but they lacked this diagnosis. Each of the three SNPs from the cis-eQTL analysis significantly increased the risk of ARDS (Table 1) . Remarkably, for each SNP, the allele associated with lower TIE2 gene expression in HapMap3 was also the risk allele for developing ARDS. Because odds ratios were calculated after adjusting for the major clinical variables significantly associated with ARDS (i.e., age, sepsis, pneumonia), the results suggested an independent effect of these TIE2 SNPs.
The haplotype predicted by cis-eQTL analysis to be associated with the highest gene expression, "TIE2-high" (C/G/A; haplotype 6 in Table S2 ), was present in 17% of the clinical cohort. In multivariable regression analysis that accounted for the strongest clinical predictors of ARDS, this haplotype was associated with 28% risk reduction (P = 0.011; Table S3 ). Indeed, compared with the haplotype predicted to be least protective, "TIE2-low" (A/A/G; haplotype 1 in Table S2 ; 42% frequency), possessing any other haplotype was associated with 31% risk reduction (P = 0.003; Table  S4 ).Together, these results suggest that common, genetically determined variation in the set point for Tie2 expression may affect clinically relevant syndromes associated with vascular leakage.
Discussion
These results show that intact Tie2 expression is necessary for barrier defense, that infections associated with severe vascular leakage are characterized by a fall in Tie2 expression, and that common variations in the level of Tie2 expression may influence the human host response to severe infection. These results broaden the focus of increasingly intense research into the Angpt-Tie2 signaling axis to consider the role of gene expression control.
The human TIE2 locus has a well-characterized promoter that consists of the 5′ flanking sequence and the first intron (25, 26) . However, all three of the highly associated SNPs found in the present cis-eQTL analysis are located in introns 3′ to these experimentally described promoter regions. Our results do not imply that introns 9, 11, and 12 are as powerful as the 5′ flank and first intron for driving TIE2 gene expression. Rather, they suggest that common variation in the degree to which TIE2 is expressed relates to haplotypes (marked by polymorphisms) at other sites in the gene locus. The identified SNPs may themselves be functional or may tag novel enhancer regions in TIE2 introns. These hypotheses remain to be determined with formal promoter regulatory studies.
The risk alleles for ARDS in an independent cohort aligned in all three instances with variants linked to reduced TIE2 expression. Although these results require additional testing and further confirmation, they suggest that small but distinct variations in basal TIE2 expression can interact with the environmental stress of infection to influence risk in critical illness. Whether these same polymorphisms influence outcomes, such as ventilator duration or overall survival, may require a more complex analysis that accounts for variation in major treatment variables, such as time to antibiotic initiation or frequency with which lungprotective ventilation was used (27) (28) (29) . It remains to be determined whether genetic variants that lower TIE2 expression contribute to worse survival outcomes, whereas variants that raise expression are associated with better outcomes.
The bulk of vascular leakage research in the Tie2 field has focused on the ligands. Angpt-1 protects against vascular leakage and death in experimental sepsis (15, 16) . Similar protective effects arise with blockade, deletion, or depletion of Angpt-2 (1, 4, 6, 30) . However, the importance of Tie2 has been diminished by the identification of integrin receptors for Angpt-1 (11-13) and, more recently, for Angpt-2 (3, 31) . Integrins appear to be low-affinity, but nonetheless critical, receptors for the Angpts in several functional contexts. Polarity of ligand presentation may be important, particularly because integrins on the basolateral surface that otherwise engage basement membrane proteins would theoretically be ideally positioned to bind pericyte-derived Angpt-1 (32). An integrin-based pathway for Angpt-2-dependent endothelial destabilization may well be important in sepsis (31) . The interaction of Tie2 with integrins merits further study.
Tie2-dependent barrier defense in the lung likely relies on maintenance of junctional VE-cadherin. Although transcriptional regulation of VE-cadherin has been described (33), Tie2 may also regulate localization of VE-cadherin through phosphorylationdependent endocytosis. For example, Tie2 may limit VE-cadherin phosphorylation by sequestering the tyrosine phosphatase VE-PTP (34, 35) . Alternatively, activated Tie2 has been shown to inhibit Src family kinases in the context of VEGF costimulation (36) . Because activated Src also promotes VE-cadherin phosphorylation downstream of multiple proinflammatory mediators (37) , intact Tie2 may be necessary to blunt Src activation. Consistent with this possibility, Tie2
low ECs exhibited increased activation of Src compared with Tie2 intact cells (Fig. S5 ). Why do so many severe infections appear to share an action on Tie2? Microbe-specific pathways may alter gene expression in the endothelium, each through a unique mechanism. For example, anthrax LT cleaves MEK1/2 in the endothelium to affect gene expression (18) , whereas Gram-negative LPSs signal through Tolllike receptor 4 to activate endothelial inflammation. There may also be secondary effects of systemic inflammation, such as reduced flow down-regulating Tie2 expression or promoting Tie2 cleavage (38, 39) . Conversely, several infectious syndromes may converge on conserved aspects of the host response, such as acute inflammatory mediators. Dissecting these and intermediate possibilities will require substantial effort, but the present studies lend this question the necessary momentum for future investigation. These results open several avenues for study. Kugathasan et al. (21) showed that compensatory changes in Angpt expression might help preserve basal Tie2 signaling when Tie2 gene expression is low. Whether similar ligand "rebalancing" is present in persons with the TIE2 low-risk allele remains to be determined. Our results suggest that barrier maintenance is an active, rather than passive, process, requiring intact Tie2 expression. Using Tie2 expression level as a "switch" for barrier regulation constitutes a previously unidentified control mechanism that may have important implications for other vascular diseases. Activation of Tie2 by Angpt-1 suppresses inflammation in vivo (15, 16 ), yet reduction of basal Tie2 expression did not have an impact on cellular or molecular inflammation (Fig. 4) . These findings suggest that Tie2 expression and Tie2 activation can have distinct consequences (i.e., withdrawal of basal Tie2 signaling may, alone, be insufficient to trigger inflammation). We speculate that a "second hit" in the form of a proinflammatory stimulus to microvascular barriers already weakened by reduced Tie2 expression may be needed to blossom the full proinflammatory, leaky phenotype commonly observed during severe infections. Finally, the possibility of assessing genetic susceptibility to vascular leakage opens important avenues for bedside application. For example, a TIE2-low haplotype suggesting leak-prone blood vessels may guide clinicians to use fluid-conservative strategies to minimize ARDS risk. Because the Tie2 pathway has been linked to an even broader array of infections than studied here, such as Ebola and Hantavirus (40, 41) , the impact of genetic determinants for Tie2 protein abundance and function merits further investigation. More broadly, genetic biomarkers of vascular leak risk could catalyze drug discovery for therapies targeting the vasculature by facilitating prognostic enrichment in clinical trials.
In summary, the present findings demonstrate that Tie2 levels may be a determinant for vascular barrier function and that they implicate TIE2 gene expression as a critical switch modulated by diverse infections associated with vascular leakage. The results suggest genetic means to identify individuals at elevated risk for infection-associated vascular complications.
Methods
Details of materials and methods are provided in SI Methods. ) littermate controls used in this study were generated as previously described on CD1 background (21) .
To achieve acute Tie2 knock down in mice, lipoplexed siTie2 or control siRNA was administered via intravenous injection as described previously (42) . The sense strand was 5′-auaucugggcaaaugaugg-3′, and the antisense strand was 5′-ccaucauuugcccagauau-3′, with the underlined nucleotides bearing 2′-Omethyl modification (42) . Animals were euthanized by exsanguination under anesthesia, followed by rapid collection of organs into liquid nitrogen for further analysis.
Cell Culture. Passage 2-6 HMVECs from dermis or lung (Lonza) were cultured in EBM-2 media (Lonza) supplemented with 5% (vol/vol) FBS and growth factors according to the manufacturer's instructions. Serum starvation was performed in EBM-2 media with 1% FBS and penicillin-streptomycin for durations as noted. Unless otherwise noted for LPS experiments, cells were treated with 100 ng/mL LPS (serotype O111:B4), CD14 (100 ng/mL), and LPS-binding protein (10 ng/mL) for the indicated period.
Genomics Methods.
Cis-eQTL analysis. To identify SNPs associated with TIE2 expression, an online database of SNPs from HapMap3 linked to transcription expression profiles was searched in a 2-Mb interval centered on the TSS of TIE2 (Genevar; Wellcome Trust Sanger Institute) (43) . Candidate SNPs were ranked by their ANOVA-derived P values for association with Tie2 transcript abundance. Functional features associated with SNPs were identified in the UCSC Genome Browser and verified in the Ensembl Genome Browser. ARDS cohort. ARDS cases and controls were identified from critically ill patients from the intensive care unit at Massachusetts General Hospital as described previously (44) . The study was reviewed and approved by the Institutional Review Board of Massachusetts General Hospital. All participants or their surrogate care providers gave written informed consent. After quality evaluation, 367 ARDS cases and 1,247 at-risk controls, as well as three candidate QTL SNPs, were enrolled in the ARDS risk analysis. For focused analysis of TIE2, SNPs were restricted to within 50 kb of the gene locus. Statistically significant SNPs identified from the cis-eQTL analysis were studied further, and their effects were modeled as individual SNPs and as haplotypes with multivariable regression.
Statistical considerations for human studies. Categorical variables were described using frequency. The χ 2 test was adopted to test the difference between proportions. Multivariable regression was used to calculate odds ratios for each SNP in an additive model for ARDS risk. Covariates, including age, gender, sepsis, pneumonia, and blood transfusion, were adjusted in the statistical model. All P values are two-sided with a significance level of 0.05. These analyses were performed using R software version 3.2.3.
Statistical Analysis. Results are presented as mean ± SEM unless otherwise noted. A P value <0.05 was considered statistically significant. Means were compared by unpaired t test, and for groups of three of more conditions, we used ANOVA with post hoc pairwise comparisons. Analysis and graphical presentation were performed using GraphPad Prism software.
